Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Cushing Syndrome II: Pathophysiology

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Chimeric antigen receptor T-cell therapy in neurological disorders: Emerging applications, evidence, and challenges.

Journal of the neurological sciences·2026

Same author

Sex differences in the association of vascular risk and APOE Genotype with cognitive decline and dementia: evidence from a U.S. longitudinal study.

Lancet regional health. Americas·2026

Same author

Organelle stresses and energetic metabolisms promote endothelial-to-mesenchymal transition and fibrosis via upregulating FOSB and MEOX1 in Alzheimer's disease.

Frontiers in molecular neuroscience·2025

Same author

Alzheimer's disease as an auto-innate immune pathology with potential cell trans-differentiation and enhanced trained immunity in 3xTg-AD mouse model.

Journal of Alzheimer's disease : JAD·2025

Same author

Innate immunity of vascular smooth muscle cells contributes to two-wave inflammation in atherosclerosis, twin-peak inflammation in aortic aneurysms and trans-differentiation potential into 25 cell types.

Frontiers in immunology·2024

Same author

A tough trek in the development of an anti-amyloid therapy for Alzheimer's disease: Do we see hope in the distance?

Journal of the neurological sciences·2022

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 15, 2010

Hyperestrogenemia simulating kennedy disease.

¹Departments of Neurology and Pharmacology, Temple University School of Medicine, Philadelphia, PA. jluo@temple.edu

Journal of Clinical Neuromuscular Disease

|December 20, 2007

Summary

This summary is machine-generated.

This study details a Kennedy disease case with normal genetics but elevated estrogen levels, likely from alcoholic fatty liver disease, causing neurological and physical symptoms. The findings highlight estrogen

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Related Experiment Videos

Last Updated: Jun 18, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 15, 2010

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Area of Science:

Neurology
Endocrinology
Genetics

Background:

Kennedy disease (spinal and bulbar muscular atrophy) is an X-linked inherited neurodegenerative disorder.
Typical genetic analysis reveals an expanded CAG repeat sequence in the androgen receptor gene.
Clinical manifestations include progressive muscle weakness, bulbar dysfunction, and endocrine abnormalities.

Observation:

A 71-year-old male presented with classic Kennedy disease symptoms: dysarthria, dysphagia, fasciculations, lower extremity weakness, gynecomastia, and testicular atrophy.
Electrophysiology revealed sensory axonal polyneuropathy and chronic neurogenic alterations.
Genetic testing showed a normal 17-CAG repeat sequence, ruling out typical Kennedy disease.
Elevated estrogen levels (180-220 pg/mL) were detected, associated with alcoholic fatty liver disease.
Ultrasound confirmed splenomegaly.

Findings:

The patient's phenotype was not explained by the typical genetic mutation for Kennedy disease.
Increased estrogen levels were identified as a potential causative factor.
Alcoholic fatty liver disease was implicated in the hormonal imbalance.
Estrogen's adverse effects on estrogen-sensitive cells (breast, testicular, neuronal, muscle) were proposed to explain the clinical presentation.

Implications:

This case suggests that elevated estrogen levels, potentially secondary to liver disease, can mimic or contribute to Kennedy disease-like symptoms.
It underscores the importance of comprehensive hormonal evaluation in atypical presentations of neurodegenerative disorders.
Further research is warranted to explore the role of hormonal imbalances in neurodegeneration and their therapeutic implications.